linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company News  
Dr. Lal Pathlabs Ltd.
 
BSE Code 539524
ISIN Demat INE600L01024
Book Value 147.52
NSE Code LALPATHLAB
Dividend Yield % 1.30
Market Cap 263258.35
P/E 51.80
EPS 30.32
Face Value 10  
02-May-2026 Dr. Lal PathLabs informs about update on acquisi...
24-Apr-2026 Dr. Lal PathLabs informs about analysts meet
30-Jan-2026 Allotment of Equity shares under ESOP
06-Jan-2026 Dr. Lal PathLabs sets new standard in preventive ...
06-Jan-2026 Dr. Lal PathLabs informs about press release
22-Dec-2025 Dr. Lal PathLabs informs about allotment of bonus...
26-Nov-2025 Dr. Lal PathLabs launches India’s first dedicated...
26-Nov-2025 Lal PathLabs informs about press release
01-Nov-2025 Dr. Lal PathLabs informs about press release
01-Nov-2025 Dr. Lal PathLabs informs about receipt of an asse...
24-Sep-2025 Dr. Lal Pathlabs gets nod to acquire property in ...
24-Sep-2025 Dr. Lal PathLabs informs about acquisition
20-Aug-2025 Dr. Lal Pathlabs pioneers AI integration in cance...
20-Aug-2025 Dr. Lal PathLabs informs about press release
20-Aug-2025 Dr. Lal Pathlabs surges on pioneering AI integrat...
Page 1 of 2
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.